Apollo Medical Holdings, Inc. announced the following leadership transitions: Brandon Sim, the company's Co-CEO, has been named President and Chief Executive Officer, effective January 19, 2024. Dr. Thomas Lam will serve as Vice Chairman of the Board of Directors and is retiring as President and Co-CEO, effective January 19, 2024. Chan Basho remains Chief Financial Officer and, in addition, has been named Chief Operating Officer, effective January 19, 2024.

Dr. Dinesh Kumar will be joining the executive team as Chief Medical Officer of ApolloMed, effective January 23, 2024. Dr. Lam, a co-founder of ApolloMed, led the Company in its growth from a private, regional organization in Southern California into a publicly traded, technology-powered integrated healthcare delivery platform empowering over 10,000 providers across the country. As part of a rigorously planned process, Mr. Sim will continue to lead ApolloMed into its next chapter of growth as President and CEO, alongside Mr. Basho, COO and CFO, and Dr. Kumar, CMO.

Dr. Dinesh Kumar, a visionary healthcare leader with over 25 years of healthcare experience, has spent his career transforming healthcare for the better, across clinical, provider group, and payer settings. Prior to his appointment as CMO of ApolloMed, Dr. Kumar served as Chief Medical and Chief Operating Officer at Alignment Healthcare. Before that, Dr. Kumar led value-based care and population health efforts as Senior Vice President of Clinical Transformation at DaVita.

Prior, he served as Chief Medical Officer of HealthCare Partners within the California market. Dr. Kumar received his medical degree from the University of Madras and completed his residency in internal medicine at Howard University. He then completed his fellowship in pulmonary and critical care medicine at Harbor-UCLA Medical Center and completed a Health Care Leadership Program at the University of California-San Francisco.